ISCO Financials 07/16/2014 07:16:46 International

ISCO Financials 07/16/2014 07:16:46
International Stem Cell Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6,147 4,567 4,532 1,568
Cost of Revenue 1,643 1,272 1,618 725
Gross Profit 4,504 3,295 2,914 843
Operating Expenses
Research and Development 3,560 3,599 4,434 3,374
Sales, General and Admin. 8,490 9,511 9,835 7,931
Non-Recurring Items - - - -
Other - - - -
Operating Income (7,546) (9,815) (11,355) (10,462)
Income From Continuing Operations
Add'l Income/Expense Items (2,930) (16) 2,184 (2,247)
Earnings Before Interest and Tax (10,476) (9,831) (9,171) (12,709)
Interest Expense 3 2 - 14
Earnings Before Tax (10,479) (9,833) (9,171) (12,723)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (10,479) (9,833) (9,171) (12,723)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (10,479) (9,833) (9,171) (12,723)
Preferred Stock and Other Adjustments - (1,504) (430) (1,561)
Net Income Applicable to Common Shareholders (10,479) (11,337) (9,601) (14,284)